IRW-News: Anixa Biosciences Inc.: Brief des CEO von Anixa Biosciences an die Aktionäre
IRW-PRESS: Anixa Biosciences Inc.: Brief des CEO von Anixa Biosciences an die Aktionäre
SAN JOSE, Kalifornien, 21.…
3,090€
14,87%
Echtzeit-Aktienkurs Anixa Biosciences Inc.
Bid:
Ask:
Nachrichten zur Anixa Biosciences Inc. Aktie
IRW-News: Anixa Biosciences Inc.: Brief des CEO von Anixa Biosciences an die Aktionäre
IRW-PRESS: Anixa Biosciences Inc.: Brief des CEO von Anixa Biosciences an die AktionäreSAN JOSE, Kalifornien, 21. Januar 2025 / IRW-Press…
H.C. Wainwright cuts Anixa Biosciences shares target amid financial performance By Investing.com
H.C. Wainwright cuts Anixa Biosciences shares target amid financial performance…
VENTYX NEWS NOTICE: Ventyx (Nasdaq: VTYX) Shareholders are Urged to Contact BFA Law about the Investigation into the Company’s Board of Directors
NEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX),…
Spruce Biosciences und HMNC Brain Health kündigen strategische Zusammenarbeit zur Entwicklung einer Behandlung für Major Depressive Disorder (MDD) an
SOUTH SAN FRANCISCO, Kalifornien & MÜNCHEN--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB) („Spruce“), ein biopharmazeutisches Unternehmen im Spätstadium, das sich auf…
VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to Contact the Firm About Ongoing Investigation
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX),…
INVESTIGATION ANNOUNCEMENT BFA LLP Announces an Ongoing Investigation into the Directors of Ventyx Biosciences, Inc. for Potential Breaches of Fiduciary Duty
NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX),…
Anixa Biosciences CEO Amit Kumar buys $96,600 in company stock By Investing.com
Anixa Biosciences CEO Amit Kumar buys $96,600 in company stock…
Anixa begins treatment of fourth patient in phase 1 ovarian cancer tiral By Investing.com
© Reuters. SAN JOSE, Calif. – Anixa Biosciences, Inc. (NASDAQ: NASDAQ:), a biotech company specializing in cancer treatment, has started…
Anixa Biosciences, Inc.: Could Anixa Biosciences Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
SAN JOSE, CA / ACCESSWIRE / August 10, 2023 / Cancer is a disease that affects millions of people around…
Insiderhandel: Chief Executive Officer verkauft Aktien von Anixa Biosciences im Wert von 42.126$
Kumar, Amit - Vorstand - Tag der Transaktion: 2023-07-31...…
Insiderhandel: President, COO & CFO kauft Aktien von Anixa Biosciences im Wert von 20.020$
Catelani, Michael - Vorstand - Tag der Transaktion: 2023-07-20...…
6 Analysts Have This to Say About Anixa Biosciences
Latest Ratings for ANIX
DateFirmActionFromTo Apr 2021HC Wainwright & Co.Initiates Coverage OnBuy Mar 2020Aegis CapitalInitiates Coverage OnBuy Dec 2019B.…
Anixa (ANIX) Falls 25% Despite Positive Breast Cancer Study Data
Anixa Biosciences (ANIX) announces positive top-line data from its phase Ia study evaluating the safety of its breast cancer vaccine.…
Form 8-K Anixa Biosciences Inc For: Apr 17
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-Q Anixa Biosciences Inc For: Jan 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…